Cargando…
Tocilizumab for refractory severe immune checkpoint inhibitor-associated myocarditis
Autores principales: | Doms, J., Prior, J.O., Peters, S., Obeid, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229714/ https://www.ncbi.nlm.nih.gov/pubmed/32425357 http://dx.doi.org/10.1016/j.annonc.2020.05.005 |
Ejemplares similares
-
Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series
por: Zhang, Robert S., et al.
Publicado: (2021) -
(68)Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis
por: Boughdad, Sarah, et al.
Publicado: (2021) -
Asymptomatic Immune Checkpoint Inhibitor-associated Myocarditis
por: Tanabe, Junya, et al.
Publicado: (2020) -
Electrocardiographic features of immune checkpoint inhibitor associated myocarditis
por: Zlotoff, Daniel A, et al.
Publicado: (2021) -
Refractory right ventricular myocarditis induced by immune checkpoint inhibitor despite therapy cessation and immune suppression
por: Mohammad, Khan O., et al.
Publicado: (2023)